Oculis
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oculis and other ETFs, options, and stocks.About OCS
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
CEORiad Sherif
CEORiad Sherif
Employees49
Employees49
HeadquartersZug, Zug
HeadquartersZug, Zug
Founded2016
Founded2016
Employees49
Employees49
OCS Key Statistics
Market cap1.11B
Market cap1.11B
Price-Earnings ratio-7.71
Price-Earnings ratio-7.71
Dividend yield—
Dividend yield—
Average volume106.22K
Average volume106.22K
High today$19.81
High today$19.81
Low today$19.43
Low today$19.43
Open price$19.50
Open price$19.50
Volume86.77K
Volume86.77K
52 Week high$23.08
52 Week high$23.08
52 Week low$14.00
52 Week low$14.00
Stock Snapshot
With a market cap of 1.11B, Oculis(OCS) trades at $19.48. The stock has a price-to-earnings ratio of -7.71.
During the trading session on 2025-12-18, Oculis(OCS) shares reached a daily high of $19.81 and a low of $19.43. At a current price of $19.48, the stock is +0.3% higher than the low and still -1.7% under the high.
Trading volume for Oculis(OCS) stock has reached 86.77K, versus its average volume of 106.22K.
Over the past 52 weeks, Oculis(OCS) stock has traded between a high of $23.08 and a low of $14.00.
Over the past 52 weeks, Oculis(OCS) stock has traded between a high of $23.08 and a low of $14.00.
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own OCS. This list is generated using Robinhood data, and it’s not a recommendation.